Press Release: Kiadis Pharma : Notice of Annual General Meeting of Shareholders
Amsterdam, The Netherlands, 13 May 202 1 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS) , a
Read full article »
Kiadis Pharma is a biopharmaceutical company that develops and commercializes T-cell based immunotherapies for the treatment of blood cancer.
Read more